Concepedia

Imad Shureiqi

IS

58

Publications

4.9K

Citations

35

H-Index

1999

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Michigan

Applied Mathematics (United States)

The University of Texas at Austin

Imad Shureiqi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pathology.

Top concepts

MedicineOncologyCancer ResearchPathologyPharmacologyTumor BiologyColorectal CancerRadiation OncologyCancer Cell BiologyCell Biology

Publications per year

1999–2023

58

Publications

58

<i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

Hui Ling, Riccardo Spizzo, Yaser Atlasi et al. · Genome Research · 2013 · 607 citations · Full text

<i>Fusobacterium</i> in Colonic Flora and Molecular Features of Colorectal Carcinoma

Tomomitsu Tahara, Eiichiro Yamamoto, Hiromu Suzuki et al. · Cancer Research · 2014 · 461 citations · Full text

Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer

Cornelius J. McGinn, Mark M. Zalupski, Imad Shureiqi et al. · Journal of Clinical Oncology · 2001 · 310 citations

Lipoxygenase modulation to reverse carcinogenesis.

Imad Shureiqi, Scott M. Lippman · PubMed · 2001 · 269 citations

Lipoxygenase Modulation, Oncology, Lox Modulators +13

The 15-lipoxygenase-1 product 13- <i>S</i> -hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells

Imad Shureiqi, Wei Jiang, Xiangsheng Zuo et al. · Proceedings of the National Academy of Sciences · 2003 · 235 citations · Full text

Down-regulates Ppar-δ, Chemoprevention Strategy, Biochemistry +15

Rows per page

1–5 of 58